 
                        | Product NDC: | 55111-329 | 
| Proprietary Name: | Nateglinide | 
| Non Proprietary Name: | Nateglinide | 
| Active Ingredient(s): | 120 mg/1 & nbsp; Nateglinide | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 55111-329 | 
| Labeler Name: | Dr. Reddy's Laboratories Limited | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA077461 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20090909 | 
| Package NDC: | 55111-329-01 | 
| Package Description: | 100 TABLET in 1 BOTTLE (55111-329-01) | 
| NDC Code | 55111-329-01 | 
| Proprietary Name | Nateglinide | 
| Package Description | 100 TABLET in 1 BOTTLE (55111-329-01) | 
| Product NDC | 55111-329 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Nateglinide | 
| Dosage Form Name | TABLET | 
| Route Name | ORAL | 
| Start Marketing Date | 20090909 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Dr. Reddy's Laboratories Limited | 
| Substance Name | NATEGLINIDE | 
| Strength Number | 120 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Glinide [EPC],Potassium Channel Antagonists [MoA] |